NCT03750942

Brief Summary

Rationale: Approximately 7000 stomata are created in the Netherlands every year. The occurrence of a parastomal herniation is high, with a reported incidence of 4-48%. Also, the former stoma site is at increased risk for the development of an incisional hernia. A clinical incisional hernia rate of 30% is reported after stoma reversal. Herniation can cause pain, deformity and possibly incarceration, which results in a significant impact on the quality of life of the patient. The hypothesis of this study is that the use of a prophylactic mesh at the time of stoma formation leads to a lower incidence of incisional hernias after stoma reversal, an improved quality of life and therefore a possible cost reduction in healthcare. Objective: To evaluate the incidence of incisional hernias after stoma reversal after preventive mesh placement compared to no mesh placement. In addition, we aim to assess the effect of preventive mesh placement on the quality of life and the effect on healthcare cost reduction by avoiding re-intervention. Study design: A multicentre double blind randomized controlled trial with a total follow up of 24 months. Study population: Adults (18-99) undergoing bowel resection with the formation of a temporary stoma. Intervention: A preventive mesh will be placed using a sublay keyhole technique (pre-peritoneal, retromuscular) at stoma formation. The mesh will be left in situ after stoma reversal and the hole in the mesh will be closed, to prevent incisional herniation. Main study parameters/endpoints:

  • Primary: Incidence of incisional hernias after stoma reversal
  • Secondary: Quality of life, stoma related prolapse or parastomal herniation, cost effectiveness and mesh related complications. Nature and extent of the burden and the risks associated with participation, benefit and group relatedness: The standard surgical procedure for the treatment of parastomal hernias is used in a prophylactic fashion. As this is standard care in parastomal hernias the risks are minimal. The mesh that is used is CE approved. The burden of participation in this study is minimal for the patient all follow-up visits coincide with the regular visits for colorectal cancer. Hence, no extra outpatient department visits, and even no additional diagnostics nor other medical procedures that could potentially burden the patient, are required.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

November 23, 2018

Status Verified

November 1, 2018

Enrollment Period

4 years

First QC Date

November 16, 2018

Last Update Submit

November 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Occurrence of incisional hernia at the former stoma site.

    Incidence of incisional hernia Expressed in % ranging from 0-100%, a lower percentage is considered a better outcome.

    24 months

Secondary Outcomes (12)

  • Occurrence of parastomal hernia

    24 months

  • Occurence of prolapse

    24 months

  • Occurence of mesh infection

    24 months

  • Occurence of wound infections

    24 months

  • Occurence of Seroma

    24 months

  • +7 more secondary outcomes

Study Arms (2)

Adhesix® monofilament polypropylene mesh (Bard Davol) group

EXPERIMENTAL

The intervention arm will receive a mesh surrounding the stoma at the time of creation of the stoma.

Device: Adhesix® monofilament polypropylene mesh (Bard Davol)

Control group

NO INTERVENTION

The control group will not receive a mesh and the stoma will be created according local protocol.

Interventions

The intervention group will receive preventive mesh placement and in the control group no mesh is placed, the stoma is closed according to standard practise.

Adhesix® monofilament polypropylene mesh (Bard Davol) group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Diagnosed with colorectal carcinoma
  • Bowel resection following stoma formation, intended to be temporary.
  • Elective surgery
  • ASA-score I-III
  • Signed informed consent

You may not qualify if:

  • Emergency operation
  • Peritonitis (i.e. bowel perforation)
  • Bowel obstruction
  • A life expectancy of less than 2 years (distant metastasis i.e. located in the liver, peritoneum, lung, cerebral or bone)
  • Earlier hernia repair with mesh placed in a 10cm proximity of the future stoma site.
  • Chronic use of antibiotics
  • Chronic use of immunosuppressive medication
  • ASA-score IV or above
  • Not able to sign informed consent
  • Patient being unable to speak Dutch
  • Patient allergic to one of the components of the mesh

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Medical Centre

Maastricht, Limburg, 6229 HX, Netherlands

Location

Related Publications (1)

  • Vu BK, Lam J, Sherman MJ, Tam MS. Prophylactic Biosynthetic Retrorectus Mesh Placement During Stoma Reversal Reduces the Rate of Stoma Site Incisional Hernia. Perm J. 2024 Jun 14;28(2):16-25. doi: 10.7812/TPP/23.115. Epub 2024 Apr 23.

MeSH Terms

Conditions

Incisional Hernia

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Nicole D Bouvy, MD, PhD

    Maastricht University Medical Centre, department of Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicole D Bouvy, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

November 16, 2018

First Posted

November 23, 2018

Study Start

March 1, 2019

Primary Completion

March 1, 2023

Study Completion

March 1, 2023

Last Updated

November 23, 2018

Record last verified: 2018-11

Locations